Please login to the form below

Not currently logged in
Email:
Password:

Hong Kong

This page shows the latest Hong Kong news and features for those working in and with pharma, biotech and healthcare.

BeiGene gets speedy US review for lymphoma drug zanubrutinib

BeiGene gets speedy US review for lymphoma drug zanubrutinib

BeiGene – which listed on the Hong Kong stock exchange last year – has suggested its drug has a best-in-class profile when it comes to potency and selectivity and has a

Latest news

More from news
Approximately 2 fully matching, plus 68 partially matching documents found.

Latest Intelligence

  • Is China ready for a pharmaceutical gold rush?

    Public trading barometer. Another potential barometer of China’s free market access will be how the sector fares on the Hong Kong Stock exchange. ... Hong Kong is an attractive spot for Chinese biotech listings as firms from here and the wider region

  • Deal Watch October 2018

    Gilead’s subsidiary, Kite, has agreed a deal for a research collaboration with HiFiBiO Therapeutics, the Hong Kong-based company which is working on the discovery of therapeutic antibodies through single

  • Chinese biotech’s global ambitions Chinese biotech’s global ambitions

    BeiGene aims to be the first home-grown big biopharma. BeiGene is one of a new wave of Chinese biopharma companies to list on the Hong Kong stock exchange, raising a ... However while there are doubts about the robustness of some of the ‘pre-revenue’

  • Biopharma's Future: Made in China Biopharma's Future: Made in China

    scale.”. Having just raised a gargantuan $903m via an IPO on the newly deregulated Hong Kong exchange, the company is bullish about becoming one of those Chinese-headquartered global pharma companies, ... In terms of biotech funding, the emergence of

  • Deal Watch February 2017 Deal Watch February 2017

    Greater China (China, Hong Kong, Macao, Taiwan). HIF, hypoxia-inducible factor prolyl hydroxylase.

More from intelligence
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics